nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2C18—Dapsone—leprosy	0.122	0.138	CbGbCtD
Ifosfamide—CYP2A6—Rifampicin—leprosy	0.0718	0.0811	CbGbCtD
Ifosfamide—PTGS1—Thalidomide—leprosy	0.0634	0.0716	CbGbCtD
Ifosfamide—PTGS1—Dapsone—leprosy	0.0507	0.0572	CbGbCtD
Ifosfamide—CYP3A7—Rifampicin—leprosy	0.0491	0.0555	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0491	0.0555	CbGbCtD
Ifosfamide—CYP2B6—Rifampicin—leprosy	0.0468	0.0528	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0405	0.0458	CbGbCtD
Ifosfamide—CYP3A7—Dapsone—leprosy	0.0405	0.0458	CbGbCtD
Ifosfamide—CYP3A5—Thalidomide—leprosy	0.038	0.043	CbGbCtD
Ifosfamide—CYP3A5—Rifampicin—leprosy	0.0368	0.0416	CbGbCtD
Ifosfamide—CYP2C8—Rifampicin—leprosy	0.0354	0.04	CbGbCtD
Ifosfamide—CYP2C19—Thalidomide—leprosy	0.0307	0.0346	CbGbCtD
Ifosfamide—CYP3A5—Dapsone—leprosy	0.0304	0.0343	CbGbCtD
Ifosfamide—CYP2C19—Rifampicin—leprosy	0.0297	0.0336	CbGbCtD
Ifosfamide—CYP2C8—Dapsone—leprosy	0.0292	0.033	CbGbCtD
Ifosfamide—CYP2C9—Thalidomide—leprosy	0.0255	0.0288	CbGbCtD
Ifosfamide—CYP2C9—Rifampicin—leprosy	0.0247	0.0279	CbGbCtD
Ifosfamide—CYP2C19—Dapsone—leprosy	0.0245	0.0277	CbGbCtD
Ifosfamide—CYP2C9—Dapsone—leprosy	0.0204	0.023	CbGbCtD
Ifosfamide—CYP3A4—Rifampicin—leprosy	0.0144	0.0162	CbGbCtD
Ifosfamide—CYP3A4—Dapsone—leprosy	0.0119	0.0134	CbGbCtD
Ifosfamide—Acute myeloid leukaemia—Thalidomide—leprosy	0.00485	0.0425	CcSEcCtD
Ifosfamide—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00485	0.0425	CcSEcCtD
Ifosfamide—Myelodysplastic syndrome—Thalidomide—leprosy	0.00397	0.0347	CcSEcCtD
Ifosfamide—Status epilepticus—Thalidomide—leprosy	0.00338	0.0296	CcSEcCtD
Ifosfamide—Swelling face—Dapsone—leprosy	0.00327	0.0286	CcSEcCtD
Ifosfamide—Tumour lysis syndrome—Thalidomide—leprosy	0.00287	0.0251	CcSEcCtD
Ifosfamide—Acute leukaemia—Thalidomide—leprosy	0.00279	0.0244	CcSEcCtD
Ifosfamide—Enuresis—Thalidomide—leprosy	0.00279	0.0244	CcSEcCtD
Ifosfamide—Septic shock—Thalidomide—leprosy	0.00264	0.0231	CcSEcCtD
Ifosfamide—Polyneuropathy—Thalidomide—leprosy	0.00244	0.0214	CcSEcCtD
Ifosfamide—Skin necrosis—Thalidomide—leprosy	0.00228	0.0199	CcSEcCtD
Ifosfamide—Pericarditis—Thalidomide—leprosy	0.00184	0.0161	CcSEcCtD
Ifosfamide—Dysaesthesia—Thalidomide—leprosy	0.00184	0.0161	CcSEcCtD
Ifosfamide—Proteinuria—Dapsone—leprosy	0.00177	0.0155	CcSEcCtD
Ifosfamide—Protein urine present—Dapsone—leprosy	0.00175	0.0153	CcSEcCtD
Ifosfamide—Skin exfoliation—Dapsone—leprosy	0.00149	0.013	CcSEcCtD
Ifosfamide—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00137	0.012	CcSEcCtD
Ifosfamide—Febrile neutropenia—Thalidomide—leprosy	0.00132	0.0116	CcSEcCtD
Ifosfamide—Deep vein thrombosis—Thalidomide—leprosy	0.00131	0.0115	CcSEcCtD
Ifosfamide—Serum creatinine increased—Thalidomide—leprosy	0.0013	0.0113	CcSEcCtD
Ifosfamide—Nail disorder—Thalidomide—leprosy	0.00123	0.0107	CcSEcCtD
Ifosfamide—Neuralgia—Thalidomide—leprosy	0.00115	0.01	CcSEcCtD
Ifosfamide—Interstitial lung disease—Thalidomide—leprosy	0.00113	0.00985	CcSEcCtD
Ifosfamide—Psychotic disorder—Dapsone—leprosy	0.0011	0.00965	CcSEcCtD
Ifosfamide—Stupor—Thalidomide—leprosy	0.00107	0.00934	CcSEcCtD
Ifosfamide—Cholestasis—Thalidomide—leprosy	0.00105	0.00918	CcSEcCtD
Ifosfamide—Pleural effusion—Thalidomide—leprosy	0.00104	0.0091	CcSEcCtD
Ifosfamide—Petechiae—Thalidomide—leprosy	0.000969	0.00847	CcSEcCtD
Ifosfamide—Endocrine disorder—Thalidomide—leprosy	0.000961	0.00841	CcSEcCtD
Ifosfamide—Pancreatitis—Dapsone—leprosy	0.000957	0.00838	CcSEcCtD
Ifosfamide—Proteinuria—Thalidomide—leprosy	0.000907	0.00793	CcSEcCtD
Ifosfamide—Amenorrhoea—Thalidomide—leprosy	0.000907	0.00793	CcSEcCtD
Ifosfamide—Protein urine present—Thalidomide—leprosy	0.000894	0.00782	CcSEcCtD
Ifosfamide—Hypocalcaemia—Thalidomide—leprosy	0.00087	0.00761	CcSEcCtD
Ifosfamide—Drug interaction—Thalidomide—leprosy	0.000859	0.00751	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Dapsone—leprosy	0.000854	0.00747	CcSEcCtD
Ifosfamide—Dyskinesia—Thalidomide—leprosy	0.000848	0.00742	CcSEcCtD
Ifosfamide—Hearing impaired—Thalidomide—leprosy	0.000837	0.00732	CcSEcCtD
Ifosfamide—Gait disturbance—Thalidomide—leprosy	0.000816	0.00714	CcSEcCtD
Ifosfamide—Pulmonary embolism—Thalidomide—leprosy	0.000797	0.00697	CcSEcCtD
Ifosfamide—Depressed level of consciousness—Thalidomide—leprosy	0.000769	0.00673	CcSEcCtD
Ifosfamide—Colitis—Thalidomide—leprosy	0.000765	0.00669	CcSEcCtD
Ifosfamide—Skin exfoliation—Thalidomide—leprosy	0.000761	0.00665	CcSEcCtD
Ifosfamide—Tinnitus—Dapsone—leprosy	0.000729	0.00638	CcSEcCtD
Ifosfamide—Pulmonary oedema—Thalidomide—leprosy	0.000709	0.0062	CcSEcCtD
Ifosfamide—Sepsis—Thalidomide—leprosy	0.000691	0.00605	CcSEcCtD
Ifosfamide—Erythema—Dapsone—leprosy	0.00068	0.00595	CcSEcCtD
Ifosfamide—Thrombophlebitis—Thalidomide—leprosy	0.000668	0.00585	CcSEcCtD
Ifosfamide—Deafness—Thalidomide—leprosy	0.000647	0.00566	CcSEcCtD
Ifosfamide—Vision blurred—Dapsone—leprosy	0.000641	0.00561	CcSEcCtD
Ifosfamide—Renal failure acute—Thalidomide—leprosy	0.000627	0.00548	CcSEcCtD
Ifosfamide—Amnesia—Thalidomide—leprosy	0.000616	0.00539	CcSEcCtD
Ifosfamide—Vertigo—Dapsone—leprosy	0.000611	0.00535	CcSEcCtD
Ifosfamide—Atrial fibrillation—Thalidomide—leprosy	0.00061	0.00534	CcSEcCtD
Ifosfamide—Cough—Dapsone—leprosy	0.000594	0.00519	CcSEcCtD
Ifosfamide—Cardiac failure—Thalidomide—leprosy	0.000593	0.00518	CcSEcCtD
Ifosfamide—Osteoarthritis—Thalidomide—leprosy	0.000578	0.00506	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000578	0.00506	CcSEcCtD
Ifosfamide—Pain in extremity—Thalidomide—leprosy	0.000578	0.00506	CcSEcCtD
Ifosfamide—Psychotic disorder—Thalidomide—leprosy	0.000565	0.00494	CcSEcCtD
Ifosfamide—Cardiac arrest—Thalidomide—leprosy	0.00055	0.00481	CcSEcCtD
Ifosfamide—Blood creatinine increased—Thalidomide—leprosy	0.000542	0.00474	CcSEcCtD
Ifosfamide—Hypokalaemia—Thalidomide—leprosy	0.000526	0.0046	CcSEcCtD
Ifosfamide—Breast disorder—Thalidomide—leprosy	0.000523	0.00457	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000521	0.00456	CcSEcCtD
Ifosfamide—Bronchospasm—Thalidomide—leprosy	0.000492	0.0043	CcSEcCtD
Ifosfamide—Pancreatitis—Thalidomide—leprosy	0.00049	0.00429	CcSEcCtD
Ifosfamide—Angina pectoris—Thalidomide—leprosy	0.000487	0.00426	CcSEcCtD
Ifosfamide—Pancytopenia—Thalidomide—leprosy	0.000475	0.00415	CcSEcCtD
Ifosfamide—Pollakiuria—Thalidomide—leprosy	0.000462	0.00404	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dapsone—leprosy	0.000454	0.00397	CcSEcCtD
Ifosfamide—Hyperglycaemia—Thalidomide—leprosy	0.000451	0.00394	CcSEcCtD
Ifosfamide—Pneumonia—Thalidomide—leprosy	0.000448	0.00392	CcSEcCtD
Ifosfamide—Infestation—Thalidomide—leprosy	0.000446	0.0039	CcSEcCtD
Ifosfamide—Infestation NOS—Thalidomide—leprosy	0.000446	0.0039	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000442	0.00387	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Thalidomide—leprosy	0.000439	0.00384	CcSEcCtD
Ifosfamide—Abdominal pain—Dapsone—leprosy	0.000439	0.00384	CcSEcCtD
Ifosfamide—Body temperature increased—Dapsone—leprosy	0.000439	0.00384	CcSEcCtD
Ifosfamide—Renal failure—Thalidomide—leprosy	0.000438	0.00383	CcSEcCtD
Ifosfamide—Myocardial infarction—Thalidomide—leprosy	0.000437	0.00382	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Thalidomide—leprosy	0.000437	0.00382	CcSEcCtD
Ifosfamide—Stomatitis—Thalidomide—leprosy	0.000434	0.0038	CcSEcCtD
Ifosfamide—Conjunctivitis—Thalidomide—leprosy	0.000433	0.00379	CcSEcCtD
Ifosfamide—Haematuria—Thalidomide—leprosy	0.000425	0.00372	CcSEcCtD
Ifosfamide—Agranulocytosis—Thalidomide—leprosy	0.000416	0.00364	CcSEcCtD
Ifosfamide—Bradycardia—Thalidomide—leprosy	0.000407	0.00356	CcSEcCtD
Ifosfamide—Hepatitis—Thalidomide—leprosy	0.0004	0.0035	CcSEcCtD
Ifosfamide—Urinary tract disorder—Thalidomide—leprosy	0.000395	0.00346	CcSEcCtD
Ifosfamide—Urethral disorder—Thalidomide—leprosy	0.000392	0.00343	CcSEcCtD
Ifosfamide—Visual impairment—Thalidomide—leprosy	0.000386	0.00337	CcSEcCtD
Ifosfamide—Erythema multiforme—Thalidomide—leprosy	0.000378	0.00331	CcSEcCtD
Ifosfamide—Eye disorder—Thalidomide—leprosy	0.000374	0.00327	CcSEcCtD
Ifosfamide—Tinnitus—Thalidomide—leprosy	0.000373	0.00326	CcSEcCtD
Ifosfamide—Cardiac disorder—Thalidomide—leprosy	0.000371	0.00325	CcSEcCtD
Ifosfamide—Angiopathy—Thalidomide—leprosy	0.000363	0.00318	CcSEcCtD
Ifosfamide—Immune system disorder—Thalidomide—leprosy	0.000361	0.00316	CcSEcCtD
Ifosfamide—Mediastinal disorder—Thalidomide—leprosy	0.000361	0.00315	CcSEcCtD
Ifosfamide—Chills—Thalidomide—leprosy	0.000359	0.00314	CcSEcCtD
Ifosfamide—Arrhythmia—Thalidomide—leprosy	0.000357	0.00313	CcSEcCtD
Ifosfamide—Alopecia—Thalidomide—leprosy	0.000354	0.00309	CcSEcCtD
Ifosfamide—Vomiting—Dapsone—leprosy	0.000353	0.00309	CcSEcCtD
Ifosfamide—Mental disorder—Thalidomide—leprosy	0.000351	0.00307	CcSEcCtD
Ifosfamide—Malnutrition—Thalidomide—leprosy	0.000348	0.00305	CcSEcCtD
Ifosfamide—Nausea—Dapsone—leprosy	0.00033	0.00289	CcSEcCtD
Ifosfamide—Vision blurred—Thalidomide—leprosy	0.000328	0.00287	CcSEcCtD
Ifosfamide—Ill-defined disorder—Thalidomide—leprosy	0.000323	0.00283	CcSEcCtD
Ifosfamide—Anaemia—Thalidomide—leprosy	0.000322	0.00282	CcSEcCtD
Ifosfamide—Agitation—Thalidomide—leprosy	0.00032	0.0028	CcSEcCtD
Ifosfamide—Angioedema—Thalidomide—leprosy	0.000318	0.00278	CcSEcCtD
Ifosfamide—Malaise—Thalidomide—leprosy	0.000314	0.00275	CcSEcCtD
Ifosfamide—Vertigo—Thalidomide—leprosy	0.000313	0.00274	CcSEcCtD
Ifosfamide—Leukopenia—Thalidomide—leprosy	0.000312	0.00273	CcSEcCtD
Ifosfamide—Palpitations—Thalidomide—leprosy	0.000308	0.00269	CcSEcCtD
Ifosfamide—Cough—Thalidomide—leprosy	0.000304	0.00266	CcSEcCtD
Ifosfamide—Convulsion—Thalidomide—leprosy	0.000302	0.00264	CcSEcCtD
Ifosfamide—Hypertension—Thalidomide—leprosy	0.000301	0.00263	CcSEcCtD
Ifosfamide—Myalgia—Thalidomide—leprosy	0.000297	0.00259	CcSEcCtD
Ifosfamide—Chest pain—Thalidomide—leprosy	0.000297	0.00259	CcSEcCtD
Ifosfamide—Arthralgia—Thalidomide—leprosy	0.000297	0.00259	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000295	0.00258	CcSEcCtD
Ifosfamide—Discomfort—Thalidomide—leprosy	0.000293	0.00256	CcSEcCtD
Ifosfamide—Confusional state—Thalidomide—leprosy	0.000287	0.00251	CcSEcCtD
Ifosfamide—Oedema—Thalidomide—leprosy	0.000284	0.00249	CcSEcCtD
Ifosfamide—Infection—Thalidomide—leprosy	0.000282	0.00247	CcSEcCtD
Ifosfamide—Nervous system disorder—Thalidomide—leprosy	0.000279	0.00244	CcSEcCtD
Ifosfamide—Thrombocytopenia—Thalidomide—leprosy	0.000278	0.00243	CcSEcCtD
Ifosfamide—Skin disorder—Thalidomide—leprosy	0.000276	0.00242	CcSEcCtD
Ifosfamide—Hyperhidrosis—Thalidomide—leprosy	0.000275	0.0024	CcSEcCtD
Ifosfamide—Anorexia—Thalidomide—leprosy	0.000271	0.00237	CcSEcCtD
Ifosfamide—Hypotension—Thalidomide—leprosy	0.000266	0.00232	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Thalidomide—leprosy	0.000259	0.00227	CcSEcCtD
Ifosfamide—Paraesthesia—Thalidomide—leprosy	0.000255	0.00223	CcSEcCtD
Ifosfamide—Dyspnoea—Thalidomide—leprosy	0.000253	0.00222	CcSEcCtD
Ifosfamide—Somnolence—Thalidomide—leprosy	0.000253	0.00221	CcSEcCtD
Ifosfamide—Decreased appetite—Thalidomide—leprosy	0.000247	0.00216	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Thalidomide—leprosy	0.000245	0.00215	CcSEcCtD
Ifosfamide—Fatigue—Thalidomide—leprosy	0.000245	0.00214	CcSEcCtD
Ifosfamide—Constipation—Thalidomide—leprosy	0.000243	0.00213	CcSEcCtD
Ifosfamide—Pain—Thalidomide—leprosy	0.000243	0.00213	CcSEcCtD
Ifosfamide—Feeling abnormal—Thalidomide—leprosy	0.000234	0.00205	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Thalidomide—leprosy	0.000232	0.00203	CcSEcCtD
Ifosfamide—Urticaria—Thalidomide—leprosy	0.000226	0.00198	CcSEcCtD
Ifosfamide—Abdominal pain—Thalidomide—leprosy	0.000225	0.00197	CcSEcCtD
Ifosfamide—Body temperature increased—Thalidomide—leprosy	0.000225	0.00197	CcSEcCtD
Ifosfamide—Hypersensitivity—Thalidomide—leprosy	0.000209	0.00183	CcSEcCtD
Ifosfamide—Asthenia—Thalidomide—leprosy	0.000204	0.00178	CcSEcCtD
Ifosfamide—Pruritus—Thalidomide—leprosy	0.000201	0.00176	CcSEcCtD
Ifosfamide—Diarrhoea—Thalidomide—leprosy	0.000195	0.0017	CcSEcCtD
Ifosfamide—Dizziness—Thalidomide—leprosy	0.000188	0.00164	CcSEcCtD
Ifosfamide—Vomiting—Thalidomide—leprosy	0.000181	0.00158	CcSEcCtD
Ifosfamide—Rash—Thalidomide—leprosy	0.000179	0.00157	CcSEcCtD
Ifosfamide—Dermatitis—Thalidomide—leprosy	0.000179	0.00157	CcSEcCtD
Ifosfamide—Nausea—Thalidomide—leprosy	0.000169	0.00148	CcSEcCtD
